FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate Vaccine
Company says vaccine covers serotypes responsible for approximately 84 percent of invasive pneumococcal disease in adults ages 50 years and older
Approximately 7 Percent of U.S. Population Uninsured in 2023
10.9 percent of adults aged 18 to 64 years were uninsured at the time of interview in 2023, as were 3.9 percent of children aged 0 to 17 years
Marked Increase in Pediatric RSV Hospitalizations Seen Postpandemic
Additionally, there have been higher advanced respiratory support needs in older children with fewer comorbidities than prepandemic
Pandemic-Era Tax Credits Made Healthcare More Affordable, But They’re Set to Expire
Pantoprazole Cuts GI Bleeding in Patients Undergoing Invasive Ventilation
Pantoprazole yields lower clinically important upper GI bleeding, with no significant change in mortality versus placebo
Preoxygenation With Noninvasive Ventilation Yields Lower Hypoxemia
Hypoxemia occurred in fewer patients in noninvasive-ventilation group than in oxygen-mask group
No Evidence That Live Vaccines Are Unsafe for Patients on Dupilumab
Systematic review shows vaccine efficacy not affected by dupilumab in general
Residual Risk Seen for Death, Postacute Sequelae in Third Year After COVID-19 Hospitalization
Risk for death remains significantly elevated in third year, as is risk for incident postacute sequelae of COVID-19
J&J Settles Talcum Powder Lawsuits From States for $700 Million
Health Care Spending Growth Projected to Outpace GDP to 2032
National health expenditures projected to have increased 7.5 percent in 2023, when COVID-19 public health emergency ended
